| Name | Title | Contact Details |
|---|
Wilcox Health System is a Lihue, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AndHealth is a digital health solution that combines behavioral and clinical care for migraine and autoimmune conditions. Their virtual Center of Excellence delivers a Migraine Reversal Program via mobile app to enable migraine reversal.
HealthStream (NASDAQ: HSTM) is dedicated to improving patient outcomes through the development of healthcare organizations` greatest asset: their people. Our solutions are used by healthcare organizations to meet their regulatory training requirements, increase patient resuscitation rates, improved their patients’ experiences of care, train their employees on the new ICD-10 coding system, manage the credentialing process of their workforce, expedite employees’ onboarding processes, streamline competency & performance management, and to meet many other requirements, goals, and objectives. With our corporate office based in Nashville, TN, HealthStream has additional offices in Laurel, MD, Brentwood, TN, Pensacola, FL, Jericho, NY, San Diego, CA, and Nashville, TN (Highland Ridge Office).)
Our mission as an organization is to serve our neighbors as expert, caring partners in their health. We do this by creating innovative, effective, affordable systems of care that our neighbors value. This is our promise to you. We call it The ChristianaCare Way. ChristianaCare has the most advanced health care technology available to help meet your needs. But more important than the technology is our commitment to partner with you to meet your individual needs. We want to care for you and help you live the healthy life you want to live.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.